Issue 6, 2019

Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors

Abstract

A new class of indole derivatives (3) have been identified as potent RSV fusion inhibitors. SAR exploration revealed that 5-Cl and the sulfonyl side chain of the indole scaffold are crucial for anti-RSV activity. Further optimization led to the discovery of a cyclic sulfone (8i) with 2 nM anti-RSV activity and a much improved PK profile compared to the non-cyclic sulfone counterpart.

Graphical abstract: Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors

Article information

Article type
Research Article
Submitted
26 Mar 2019
Accepted
30 Apr 2019
First published
06 May 2019

Med. Chem. Commun., 2019,10, 970-973

Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors

X. Zheng, C. Liang, L. Wang, K. Miao, B. Wang, W. Zhang, D. Chen, G. Wu, W. Zhu, L. Guo, S. Feng, L. Gao, H. C. Shen and H. Yun, Med. Chem. Commun., 2019, 10, 970 DOI: 10.1039/C9MD00178F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements